Stay updated on Ertugliflozin in Pediatric T2DM Clinical Trial
Sign up to get notified when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.

Latest updates to the Ertugliflozin in Pediatric T2DM Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe site footer’s revision label changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check22 days agoChange DetectedA site-wide NIH notice explains that agencies are transitioning terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.SummaryDifference0.2%

- Check29 days agoChange DetectedThe website footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check36 days agoChange DetectedThe site footer now identifies the ClinicalTrials.gov release as v3.7.1 instead of v3.7.0.SummaryDifference0.0%

- Check57 days agoChange DetectedA new revision entry Revision: v3.7.0 was added to the study's history, indicating an updated version of the record on ClinicalTrials.gov. The previous Revision: v3.6.6 entry was removed from the visible history, reflecting the current set of revisions.SummaryDifference0.0%

- Check71 days agoChange DetectedProvided data contains no additions or deletions to evaluate. There are no substantive text changes described beyond the existing version history.SummaryDifference0.0%

Stay in the know with updates to Ertugliflozin in Pediatric T2DM Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ertugliflozin in Pediatric T2DM Clinical Trial page.